1-1 of 1
Richard J. Klasa
Close
Sort by
Journal Articles

Long-term outcomes of R-CEOP show curative potential in patients with DLBCL and a contraindication to anthracyclines

Clinical Trials & Observations
Alden A. Moccia, Kimberly Schaff, Ciara Freeman, Paul J. Hoskins, Richard J. Klasa, Kerry J. Savage, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors, Laurie H. Sehn
Journal: Blood Advances
Blood Adv (2021) 5 (5): 1483–1489.
https://doi.org/10.1182/bloodadvances.2020002982
Published: 2021
Includes: Supplemental data